AI-Driven Autonomous Registration in Robotic Bronchoscopy
Recruiting
N/A
Interventional Study
Lung Nodules
Bronchoscopy
Localization Efficiency
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Device Feasibility
- Participants needed
- 20 (estimated)
- Sponsor
- Ruijin Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the feasibility and safety of an artificial intelligence (AI)-driven autonomous registration technology in robotic navigational bronchoscopy. A total of 20 patients with pulmonary nodules requiring localization will be enrolled. The Langhe Bronchoscopy Robot System equipped with AI-based autonomous registration software will be used. Primary outcomes include the success…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years.
* Radiologically confirmed pulmonary nodules requiring preoperative localization.
* Scheduled for robotic navigational bronchoscopy using the Bronchoscopy Robot System.
* Willing to provide written informed consent.
Exclusion Criteria:
* Severe cardiopulmonar…
Contacts